---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-000118"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2022-01-03T23:59:59+00:00"
generated_at: "2026-06-27T21:25:31.821561+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Nutriband receives Korean patent for abuse-deterrent transdermal system AVERSA

## Summary
- Korean Intellectual Property Office issued full patent titled 'Abuse and Misuse Deterrent Transdermal System'.
- Patent supports 4p Therapeutics' AVERSA fentanyl transdermal system using taste aversion.
- Company previously received notice of allowance in December 2020.

## SEC filing metadata
- accession: 0001213900-22-000118
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2022-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/0001213900-22-000118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/ea153351-8k_nutribandinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-000118
- JSON: https://secwatch.observer/filing/0001213900-22-000118.json
- Plain text: https://secwatch.observer/filing/0001213900-22-000118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.